Efficacy of esketamine nasal spray over quetiapine extended release over the short and long term: sensitivity analyses of escape-trd, a randomised phase iiib clinical trial

HIGHLIGHTS

• What: Aim Here, the authors explore the robustness of the main findings from the ESCAPE-TRD study through extensive sensitivity analyses. Throughout the trial, no patients were considered to have relapsed based on this clinical judgement criterion alone. These time to event analyses provide a time-based component to this analysis where before only binary end-points were reported for the ESCAPE-TRD study .
• Who: . doi and colleagues from the , https://doiorg/10.1192/bjp.2024., Published online by Cambridge University Press have published the article: Efficacy of esketamine nasal spray over quetiapine extended release . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.